Velangi PS et al (2019) Long-term embolic outcomes after detection of left ventricular thrombus by late gadolinium enhancement cardiovascular magnetic resonance imaging: a matched cohort study. Circ Cardiovasc Imaging 12(11):e009723

Article  PubMed  PubMed Central  Google Scholar 

Solheim S et al (2010) Frequency of left ventricular thrombus in patients with anterior wall acute myocardial infarction treated with percutaneous coronary intervention and dual antiplatelet therapy. Am J Cardiol 106(9):1197–1200

Article  PubMed  Google Scholar 

Sacoransky E et al (2024) Incidence of left ventricular thrombus following STEMI in the modern era via multimodality imaging: A systematic review and meta-analysis. IJC Heart Vasc 52:101396

Article  Google Scholar 

Shrestha DB et al (2023) Direct oral anticoagulants (DOAC) versus vitamin K antagonist in left ventricular thrombus: An updated meta-analysis. Health Sci Rep. https://doi.org/10.1002/hsr2.1736

Article  PubMed  PubMed Central  Google Scholar 

Haller PM et al (2024) Oral anticoagulation in patients with left ventricular thrombus—a systematic review and meta-analysis. Eur Heart J–Cardiovasc Pharmacother. https://doi.org/10.1093/ehjcvp/pvae042

Article  PubMed  Google Scholar 

O’Gara PT et al (2013) 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the American College of Emergency Physicians and Society for Cardiovascular Angiography and Interventions. Catheter Cardiovasc Interv 82(1):E1-27

PubMed  Google Scholar 

Kleindorfer DO et al (2021) 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke 52(7):e364–e467

Article  PubMed  Google Scholar 

Byrne RA et al (2023) 2023 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J 44(38):3720–3826. https://doi.org/10.1093/eurheartj/ehad191 (Erratum in: Eur Heart J (2024) 45(13):1145. https://doi.org/10.1093/eurheartj/ehad870)

Hu T et al (2024) Comparative effectiveness and safety of DOACs vs VKAs in treatment of left ventricular thrombus- a meta-analysis update. Thromb J 22(1):23

Article  PubMed  PubMed Central  CAS  Google Scholar 

Hutton B et al (2015) The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med 162(11):777–784

Article  PubMed  Google Scholar 

Sterne JAC et al (2019) RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ 366:l4898

Article  PubMed  Google Scholar 

Sterne JA et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ 355:i4919

Article  PubMed  PubMed Central  Google Scholar 

Guyot P et al (2012) Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves. BMC Med Res Methodol 12(1):9

Article  PubMed  PubMed Central  Google Scholar 

Grambsch PM, Therneau TM (1994) Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 81(3):515–526

Article  Google Scholar 

Abdelnabi M et al (2021) Comparative study of oral anticoagulation in left ventricular thrombi (No-LVT Trial). J Am Coll Cardiol 77(12):1590–1592

Article  PubMed  Google Scholar 

Abdi IA et al (2022) Retrospective analysis of left ventricular thrombus among heart failure patients with reduced ejection fraction at a single tertiary care hospital in Somalia. Open Access Emerg Med 14:591–597

Article  PubMed  PubMed Central  Google Scholar 

Albabtain MA et al (2021) Rivaroxaban versus warfarin for the management of left ventricle thrombus. Egypt Heart J. https://doi.org/10.1186/s43044-021-00164-7

Article  PubMed  PubMed Central  Google Scholar 

Alcalai R et al (2022) Apixaban vs. warfarin in patients with left ventricular thrombus: a prospective multicentre randomized clinical trial (double dagger). Eur Heart J-Cardiovasc Pharmacother 8(7):660–667

Article  PubMed  Google Scholar 

Bass ME et al (2021) Comparative effectiveness of direct oral anticoagulants and warfarin for the treatment of left ventricular thrombus. J Thromb Thrombolysis 52(2):517–522

Article  PubMed  CAS  Google Scholar 

Daher J et al (2020) Management of left ventricular thrombi with direct oral anticoagulants: retrospective comparative study with vitamin K antagonists. Clin Drug Investig 40(4):343–353

Article  PubMed  CAS  Google Scholar 

Fleddermann AM et al (2019) Efficacy of direct acting oral anticoagulants in treatment of left ventricular thrombus. Am J Cardiol 124(3):367–372

Article  PubMed  CAS  Google Scholar 

Guddeti RR et al (2020) Treatment of left ventricular thrombus with direct oral anticoagulants: a retrospective observational study. Am J Med 133(12):1488–1491

Article  PubMed  CAS  Google Scholar 

Iqbal H et al (2020) Direct oral anticoagulants compared to vitamin K antagonist for the management of left ventricular thrombus. Esc Heart Fail 7(5):2032–2041

Article  PubMed  PubMed Central  Google Scholar 

Isa WYHW et al (2020) Apixaban versus warfarin in patients with left ventricular thrombus: a pilot prospective randomized outcome blinded study investigating size reduction or resolution of left ventricular thrombus. J Clin Prev Cardiol 9(4):150–154

Article  Google Scholar 

Jones DA et al (2021) The use of novel oral anticoagulants compared to vitamin K antagonists (warfarin) in patients with left ventricular thrombus after acute myocardial infarction. Eur Heart J-Cardiovasc Pharmacother 7(5):398–404

Article  PubMed  Google Scholar 

Liang J et al (2022) Efficacy and safety of direct oral anticoagulants in the treatment of left ventricular thrombus after acute anterior myocardial infarction in patients who underwent percutaneous coronary intervention. Curr Vasc Pharmacol 20(6):517–526

Article  PubMed  CAS  Google Scholar 

Ratnayake CBB et al (2020) Left ventricular thrombus after ST segment elevation myocardial infarction: a single-centre observational study. N Z Med J 133(1526):45–54

PubMed  Google Scholar 

Saeed MB et al (2023) Comparison of safety and outcomes of warfarin versus rivaroxaban for treating left ventricular thrombus. NeuroQuantology 21(6):602–608

Google Scholar 

Willeford A et al (2021) Direct oral anticoagulants versus warfarin in the treatment of left ventricular thrombus. Ann Pharmacother 55(7):839–845

Article  PubMed  CAS  Google Scholar 

Youssef AA et al (2023) Apixaban in patients with post-myocardial infarction left ventricular thrombus: a randomized clinical trial. CJC Open 5(3):191–199

Article  PubMed  Google Scholar 

Zhang Q et al (2022) Rivaroxaban in heart failure patients with left ventricular thrombus: A retrospective study. Front Pharmacol. https://doi.org/10.3389/fphar.2022.1008031

Article  PubMed  Google Scholar 

Zhang ZF et al (2022) Rivaroxaban versus Vitamin K Antagonists (warfarin) based on the triple therapy for left ventricular thrombus after ST-Elevation myocardial infarction. Heart Vessel 37(3):374–384

Article  Google Scholar 

Kam KKH, Chan JSK, Lee APW (2024) Non-vitamin K oral anticoagulants versus warfarin for the treatment of left ventricular thrombus. Hong Kong Med J 30(1):10–15

PubMed  CAS  Google Scholar 

Zhou Y et al (2024) Direct oral anticoagulants compared with warfarin in patients with left ventricular thrombus: a cohort study from China. J Thorac Dis 16(2):884–892

Article  PubMed  PubMed Central  Google Scholar 

Frost C et al (2014) A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban. Clin Pharmacol 6:179–187

PubMed  PubMed Central